These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15609785)

  • 21. Typhoid vaccination: the Asian experience.
    DeRoeck D; Ochiai RL; Yang J; Anh DD; Alag V; Clemens JD
    Expert Rev Vaccines; 2008 Jul; 7(5):547-60. PubMed ID: 18564010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implementing rotavirus vaccination in Asia.
    Santosham M; Nelson EA; Bresee JS
    Vaccine; 2007 Nov; 25(44):7711-6. PubMed ID: 17881099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
    Lam SK; Burke D; Capeding MR; Chong CK; Coudeville L; Farrar J; Gubler D; Hadinegoro SR; Hanna J; Lang J; Lee HL; Leo YS; Luong CQ; Mahoney R; McBride J; Mendez-Galvan J; Ng LC; Nimmannitya S; Ooi EE; Shepard D; Smit J; Teyssou R; Thomas L; Torresi J; Vasconcelos P; Wirawan DN; Yoksan S
    Vaccine; 2011 Nov; 29(51):9417-22. PubMed ID: 21864627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The decision making process on new vaccines introduction in South Africa.
    Ngcobo NJ; Cameron NA
    Vaccine; 2012 Sep; 30 Suppl 3():C9-13. PubMed ID: 22939028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-country cluster randomized controlled effectiveness evaluation to accelerate the introduction of Vi polysaccharide typhoid vaccine in developing countries in Asia: rationale and design.
    Acosta CJ; Galindo CM; Ali M; Elyazeed RA; Ochiai RL; Danovaro-Holliday MC; Page AL; Thiem VD; Jin Y; Park JK; Lee H; Puri MK; Ivanoff B; Agtini MD; Soeharno R; Simanjuntak CH; Punjabi NH; Canh DG; Sur D; Nizami Q; Manna B; Bai-qing D; Anh DD; Honghui Y; Bhattacharya SK; Bhutta Z; Trach DD; Xu ZY; Pang T; Donner A; Clemens JD
    Trop Med Int Health; 2005 Dec; 10(12):1219-28. PubMed ID: 16359401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human vaccine research and development: an overview.
    Kieny MP; Girard MP
    Vaccine; 2005 Dec; 23(50):5705-7. PubMed ID: 16182415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Useful advice on health research data: too little attention paid to the data needs of policy makers].
    Schellevis FG
    Ned Tijdschr Geneeskd; 2009; 153():A71. PubMed ID: 19818188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decision-makers and the usefulness of research evidence in policy implementation--a case study from Lao PDR.
    Tomson G; Paphassarang C; Jönsson K; Houamboun K; Akkhavong K; Wahlström R
    Soc Sci Med; 2005 Sep; 61(6):1291-9. PubMed ID: 15970238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An optimization model for reducing typhoid cases in developing countries without increasing public spending.
    Lauria DT; Maskery B; Poulos C; Whittington D
    Vaccine; 2009 Mar; 27(10):1609-21. PubMed ID: 19146902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introducing multiple vaccines in low- and lower-middle-income countries: issues, opportunities and challenges.
    Gordon WS; Jones A; Wecker J
    Health Policy Plan; 2012 May; 27 Suppl 2():ii17-26. PubMed ID: 22513729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The introduction of new vaccines into developing countries. IV: Global Access Strategies.
    Mahoney RT; Krattiger A; Clemens JD; Curtiss R
    Vaccine; 2007 May; 25(20):4003-11. PubMed ID: 17363119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative.
    Jauregui B; Sinha A; Clark AD; Bolanos BM; Resch S; Toscano CM; Matus CR; Andrus JK
    Vaccine; 2011 Jan; 29(5):1099-106. PubMed ID: 21144916
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PneumoADIP: an example of translational research to accelerate pneumococcal vaccination in developing countries.
    Levine OS; Cherian T; Shah R; Batson A
    J Health Popul Nutr; 2004 Sep; 22(3):268-74. PubMed ID: 15609779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishing global policy recommendations: the role of the Strategic Advisory Group of Experts on immunization.
    Duclos P; Okwo-Bele JM; Salisbury D
    Expert Rev Vaccines; 2011 Feb; 10(2):163-73. PubMed ID: 21332266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The health belief model and factors relating to potential use of a vaccine for shigellosis in Kaeng Koi district, Saraburi province, Thailand.
    Butraporn P; Pach A; Pack RP; Masngarmmeung R; Maton T; Sri-aroon P; Nyamete A; Chaicumpa W
    J Health Popul Nutr; 2004 Jun; 22(2):170-81. PubMed ID: 15473520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rotavirus vaccines for infants in developing countries in Africa and Asia: considerations from a world health organization-sponsored consultation.
    Steele AD; Patel M; Parashar UD; Victor JC; Aguado T; Neuzil KM
    J Infect Dis; 2009 Nov; 200 Suppl 1():S63-9. PubMed ID: 19817616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Will dengue vaccines be used in the public sector and if so, how? Findings from an 8-country survey of policymakers and opinion leaders.
    Douglas DL; DeRoeck DA; Mahoney RT; Wichmann O
    PLoS Negl Trop Dis; 2013; 7(3):e2127. PubMed ID: 23516658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.